The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy
Open accessAbstract
Summary: It is estimated 20–25% of the epileptic patients fails to achieve good control with the different antiepileptic drugs (AEDs) treatments, developing refractory epilepsy (RE). Discovered first in cancer, the activity of P‐glycoprotein (P‐gp) and others ABC transporters as multidrug‐resistance‐associated proteins (MRPs) and breast cancer resistant protein (BCRP) are directly related with the refractoriness. We have observed the overexpression of these all transporters in the brain of patients with RE, and according with other authors, all these data suggests an active drug efflux from brain. Both constitutive and seizure induced brain P‐gp overexpression was also suggested. As confirmation of these clinical evidences, different models of experimental epilepsy have demonstrated P‐gp overexpression on blood brain barrier (BBB) and brain parenchyma cells, as astrocytes and neurons. In our model, early P‐pg detection in vessel‐related cells and later additional P‐gp detection in neurons, correlated with the gradual loss of protective effect of phenytoin. The progressive neuronal P‐gp expression, depending on intensity and time‐constancy of seizure‐injury, was in agreement with the development of “P‐gp‐positive seizure‐axis” proposed by Kwan & Brodie, who also showed that the development of RE directly correlated with the number and frequency of seizures before initiation of drug therapy. P‐gp expression in excretory organs suggests that P‐gp have a central role in drug elimination. Persistent low levels of AEDs in plasma and P‐gp brain overexpression in several RE pediatric patients were reported. We also observed in adult RE patients, an increased liver clearance of 99m Tc‐hexakis‐2‐methoxyisobutylisonitrile (99m Tc‐MIBI) (a P‐gp substrate), and the surgically treated cases showed P‐gp brain overexpression. These results suggest the systemic hyperactivity of P‐gp in RE patients, including brain P‐gp over‐expression should be suspected when persistent subtherapeutic levels of AEDs in plasma are detected. P‐gp neuronal expression described in both clinical and experimental reports indicates that additional mechanisms could be operative from seizure‐affected P‐gp‐positive neurons, due to AEDs targets are expressed at membrane level. An alternative mechanism was demonstrated in P‐gp‐expressed cells that exhibit lower membrane potential (Δψ 0=−10 to –20) compared to normal physiological Δψ 0 of –60 mV. Under this situation and irrespective to the P‐gp pharmacoresistant property or type of drug treatment selected, P‐gp‐expressed neurons could increase their sensitivity to new seizures perhaps as an epileptogenic mechanism. The understanding of properties of these ABC transporters can offer new tools for better selection of more effective preventive or therapeutic strategies and avoid the invasive surgical treatments for RE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Cited by
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
Tang, F., Hartz, A. M. S., & Bauer, B. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00301 · Cited by 482
Antiepileptic drug interactions—Principles and clinical implications
I. Johannessen, S., & Johannessen Landmark, C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246254 · Cited by 343
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs
Zaccara, G., & Perucca, E. (2014) · Epileptic Disorders · doi:10.1684/epd.2014.0714 · Cited by 305
Metadata
- Authors
- Lazarowski, A., Czornyj, L., Lubienieki, F., Girardi, E., Vazquez, S., & D'Giano, C.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2007-09
- Volume
- 48
- Issue
- s5
- Pages
- 140-149
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2079476893
- Cited by
- 239
- References
- 1
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy. https://app.cochat.ai/papers/10.1111/j.1528-1167.2007.01302.x
- The paper
- Lazarowski, A., Czornyj, L., Lubienieki, F., Girardi, E., Vazquez, S., & D'Giano, C. (2007). ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01302.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.